Rafael L. Castro - Publications

Biomarker landscape in advanced NSCLC: insights from a national prospective registry.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 23, 2025

Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 12, 2025

Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics.

Journal: BMC cancer

Published: January 19, 2022

Lung cancer patients with COVID-19 in Spain: GRAVID study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 16, 2021

Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group.

Journal: BMC cancer

Published: September 20, 2020

Forearm Metastases as Unsuspected First Manifestations of Lung Adenocarcinoma.

Journal: Turkish thoracic journal

Published: June 19, 2017

The degeneration and replacement of dopamine cells in Parkinson's disease: the role of aging.

Journal: Frontiers in neuroanatomy

Published: June 16, 2014

Melatonin prevents dopaminergic cell loss induced by lentiviral vectors expressing A30P mutant alpha-synuclein.

Journal: Histology and histopathology

Published: February 28, 2013